Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 123 for “"Virotherapy"”.

  1. Mathematical modelling of oncolytic virotherapy

    … with mathematical modelling of oncolytic virotherapy: the use of genetically modified viruses to selectively spread, replicate and destroy cancerous cells in solid tumours. Traditional spatially-dependent modelling approaches have previously assumed that virus spread is due to viral …

    oxford Repository record for Mathematical modelling of oncolytic virotherapy (opens in a new tab)

  2. Pharmacological Improvement of Oncolytic Virotherapy

    … We postulate that resistance to oncolytic virotherapy results in part from the failure of tumor cells to be sufficiently infected. In this study, we provide evidence that in the context of sarcoma, a highly heterogeneous malignancy, the infection of tumors by different oncolytic viruses …

    ottawa-retro Repository record for Pharmacological Improvement of Oncolytic Virotherapy (opens in a new tab)

  3. Improving intraperitoneal adenovirus virotherapy for ovarian cancer

    <p>The use of intraperitoneal (i.p.) adenovirus virotherapy of ovarian cancer is currently limited by insufficient efficacy and high toxicity. Both factors are associated with adenovirus serotype 5 (Ad5) in this setting and may be serotype-specific. Low levels of uptake receptors (CAR and αV …

    oxford Repository record for Improving intraperitoneal adenovirus virotherapy for ovarian cancer (opens in a new tab)

  4. Cavitation-enhanced tumour-targeting virotherapy by ultrasound

    <p>Systemic administration of adenovirus type 5 (Ad5) vectors for the treatment of cancer is limited by poor circulation kinetics and inefficient uptake from the bloodstream into tumours. This study reports a novel method for linkage of highly-PEGylated gold nanoparticles (AuPEG) to Ad5 by a single …

    oxford Repository record for Cavitation-enhanced tumour-targeting virotherapy by ultrasound (opens in a new tab)

  5. Enhancing Oncolytic Virotherapy Using Functional Genomic Screening

    … of cancer patients with oncolytic vaccinia virotherapy has yielded encouraging results in early phase clinical trials, but there are yet unexplored opportunities for improving this therapy that could lead to even better outcomes for patients. To this end, we harnessed the power of functional …

    ottawa-retro Repository record for Enhancing Oncolytic Virotherapy Using Functional Genomic Screening (opens in a new tab)

  6. Enhancement of oncolytic herpes simplex type 1 virotherapy

    Despite excellent safety data, antitumor efficacy of the oncolytic herpes simplex virus type 1 (oHSV-1) in glioblastoma (GBM) patients is not satisfactory. A major enhancement of the oncolytic activity of the oHSV-1 is necessary to eradicate the GBM in clinics. To enhance the efficacy and tumour …

    ubc Repository record for Enhancement of oncolytic herpes simplex type 1 virotherapy (opens in a new tab) Download PDF for Enhancement of oncolytic herpes simplex type 1 virotherapy (opens in a new tab)

  7. Engineering Large DNA Viruses for Enhanced Oncolytic Virotherapy

    Oncolytic viruses (OVs) offer a promising approach to cancer immunotherapy, but challenges in safety, efficacy, and engineering complex platforms remain. This thesis addresses these hurdles with novel tools and strategies. We designed an array of chemically inducible systems, controlled by …

    ottawa-retro Repository record for Engineering Large DNA Viruses for Enhanced Oncolytic Virotherapy (opens in a new tab)

  8. Improved oncolytic virotherapy by increasing virus spread within tumors.

    Oncolytic adenoviruses (Ads) have great therapeutic potential for lung cancer. Cancer selective E1b-deleted Ads are safe, however their efficacy remains limited clinically. To improve E1b-deleted Ads, Adhz60 was selected for greater anti-cancer efficacy by a process called bioselection, producing …

    louisville Repository record for Improved oncolytic virotherapy by increasing virus spread within tumors. (opens in a new tab)

  9. Characterization of Novel Small Molecule Potentiators of Oncolytic Virotherapy

    The use of oncolytic viruses (OVs) to selectively destroy cancer cells is poised to make a major impact in the clinic and potentially revolutionize cancer therapy. Pre-clinical and clinical studies have shown that OV therapy is safe, well-tolerated and effective in a broad range of cancers. Still, …

    ottawa-retro Repository record for Characterization of Novel Small Molecule Potentiators of Oncolytic Virotherapy (opens in a new tab)

  10. Macrophage delivered oncolytic virotherapy in triple negative breast cancer

    … immunotherapy-based treatments such as oncolytic virotherapy. Oncolytic virotherapy initiates immune cell activation against cancer cells through direct cell lysis and the induction of immunogenic cell death. The overarching hypothesis of this thesis is to assess the suitability of an HSV-1 …

    whiterose Download PDF for Macrophage delivered oncolytic virotherapy in triple negative breast cancer (opens in a new tab)

  11. Oncolytic Virotherapy for the Treatment of Non-Hodgkin Lymphoma

    Non-Hodgkin Lymphoma (NHL) is a diverse group of more than 80 predominantly B cell cancers of the lymphatic system. Poor survival rates in aggressive subsets, the transformation of indolent subsets into aggressive forms, and the emergence of therapy-resistance warrants research into novel …

    whiterose Download PDF for Oncolytic Virotherapy for the Treatment of Non-Hodgkin Lymphoma (opens in a new tab)

  12. Immune cell carriers and humoral immunity in oncolytic virotherapy

    … evidence suggests that NAb may in fact support virotherapy in mice by facilitating reovirus carriage upon circulating immune cells, principally monocytes. In this thesis, the applicability of these observations to the human setting is examined, modelling the loading of monocytes with reovirus in …

    whiterose Download PDF for Immune cell carriers and humoral immunity in oncolytic virotherapy (opens in a new tab)

  13. Multi-omics analysis of a Zika virus-based oncolytic virotherapy

    … has potential as a novel candidate for oncolytic virotherapy in central nervous system (CNS) tumours, including paediatric brain tumours, owning to its neurotropism and ability to kill tumour cells in vitro, as well as reducing tumour growth and extending survival in vivo. Neuroblastoma, the most …

    soton Repository record for Multi-omics analysis of a Zika virus-based oncolytic virotherapy (opens in a new tab) Download PDF for Multi-omics analysis of a Zika virus-based oncolytic virotherapy (opens in a new tab)

  14. Oncolytic Virotherapy Mediated Anti-Tumor Response: a Single-Cell Perspective

    zurich Restricted access

  15. Improving the effectiveness of oncolytic virotherapy: insights from mathematical modelling

    … whose application is not exclusive to oncolytic virotherapy. This framework adopts either a pointwise or a density-based description for the cells, according to their phenotype: transitions between the two descriptions are assumed to happen stochastically and are affected by environmental …

    poli-torino Repository record for Improving the effectiveness of oncolytic virotherapy: insights from mathematical modelling (opens in a new tab)

  16. Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer

    … posed by radiation and chemotherapy. Oncolytic virotherapy of cancer is based on the use of replication competent, tumor selective viruses with limited toxicity. Newcastle Disease Virus (NDV), an avian paramyxovirus, is a safe and promising OV successfully used in many clinical trials. NDV is …

    vt Repository record for Targeted Oncolytic Virotherapy Using Newcastle Disease Virus Against Prostate Cancer (opens in a new tab)

  17. EFFECTIVE GENE-VIROTHERAPY FOR COMPLETE ERADICATION OF TUMOR FOR PRECLINICAL STUDIES

    Proliferation-dependent transcriptional activation that is endogenously triggered could provide a means of improving the efficiency of cancer gene therapy. In this study, we demonstrate that transgene expression could be targeted to proliferating human hepatocellular carcinoma (HCC). This is …

    nus Repository record for EFFECTIVE GENE-VIROTHERAPY FOR COMPLETE ERADICATION OF TUMOR FOR PRECLINICAL STUDIES (opens in a new tab) Download file for EFFECTIVE GENE-VIROTHERAPY FOR COMPLETE ERADICATION OF TUMOR FOR PRECLINICAL STUDIES (opens in a new tab)

  18. Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains

    … remain for the clinical translation of oncolytic virotherapy. These challenges include the potential safety risk of replication of oncolytic virus in non-tumor tissue, the relatively poor virus spread throughout solid tumor tissue and the disadvantageous ratio between anti-viral and anti-tumoral …

    wurz-thes Repository record for Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains (opens in a new tab)

Page 1 of 7